Submit Deal

ONCIMMUNE LIMITED

Summary

Oncimmune, is an immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease, and infectious diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 13 M

Avg. Deal Size£ 13 M

Market Context

Sort

22 May 2023|Germany|Biotechnology

Target: ONCIMMUNE LIMITED

Bidder: FREENOME

6 Service Providers

2 Target | 1 Bidder | 3 Vendor

11 Dealmakers

2 Target | 2 Bidder | 9 Vendor

£ 13 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy